Atypical Hemolytic Uremic Syndrome Market Outlook 2025-2035: The 7 major Atypical Hemolytic Uremic Syndrome markets are expected to exhibit a CAGR of 4.1% during 2025-2035. There is growth in the ...

Jean Perrin brand Morbier de Scey and Raclette de Scey (cheeses) are under recall in Canada because of contamination with ...

Solid Biosciences has surged back into the Duchenne muscular dystrophy (DMD) gene therapy race. | Solid Biosciences has ...

Solid Biosciences' SGT-003 gene therapy showed strong dystrophin expression, muscle health improvements, and no serious safety concerns in early trial data.

Klinefelter syndrome is a genetic condition that affects only males. Here's what you should know about the causes, symptoms, and treatment options for the condition. Klinefelter syndrome is a genetic ...

Solid Biosciences (SLDB) announced initial data from the Phase 1/2 INSPIRE DUCHENNE trial evaluating SGT-003, a next-generation gene therapy ...

Day 90 biopsy data reported from first 3 participants dosed in Phase 1/2 INSPIRE DUCHENNE trial —— Average microdystrophin ...

Medically reviewed by Kashif J. Piracha, MD The A/G ratio measures the total amount of protein in your body by comparing the ...

Reversible posterior leukoencephalopathy syndrome is characterized clinically by headache, abnormalities of mental status and visual perception, and seizures. Despite its diverse causes ...

-- Vietnam won the gold medal in the men’s 25m rapid fire pistol event at the Asian Rifle/Pistol Cup 2025 in Bangkok on ...

Tremtelectogene empogeditemcel (trem-cel) may make gemtuzumab ozogamicin maintenance safer for patients with high-risk acute myeloid leukemia (AML), according to results of a phase 1/2 trial presented ...

[Analysis of a twin pregnancy with false negative result for 22q11.2 deletion syndrome by expanded non-invasive prenatal testing]. [Discussion on the status quo and solutions to the prevention and ...